Real-World outcomes in COPD patients starting Trixeo (budesonide/glycopyrronium/formoterol) in Spain.

Trial Identifier: D5980R00096
Sponsor: AstraZeneca
Start Date: July 2024
Primary Completion Date: December 2024
Study Completion Date: December 2024
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Spain Barcelona, Spain
Spain Granada, Spain
Spain Lleida, Spain
Spain Lugo, Spain
Spain Madrid, Spain
Spain Malaga, Spain
Spain Murcia, Spain
Spain Ourense, Spain
Spain Oviedo, Spain
Spain Palma de Mallorca, Spain
Spain Santa Cruz de Tenerife, Spain
Spain Sevilla, Spain
Spain Valencia, Spain
Spain Vitoria, Spain
Spain Zaragoza, Spain